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ABSTRACT
This study was aimed at comparing the influence of anti bZP3’s passive immunization on anti-
anti bZP3’s titer and pregnancy level on Wistar rats and mice. This study employed factorial design 
experiment with completely randomized design. The first factor was immunogenic type. The treated 
rats were immunized with 100 PL anti bZP3 in 100 PL Complete Freund’s Adjuvant (CFA), while the 
treated mice were injected with 50 PL anti bZP3 in 50 PL CFA. Control Wistar rats and mice were 
immunized with CFA and Incomplete Freund’s Adjuvant (IFA) without anti bZP3. The second factor 
was animal type. The third factor was the length of serum incubation, i.e. 38, 49, 63, 86, 100, and 126 
d. Dot blot on the treated Wistar rats and mice showed positive response proven by blue gradation; 
pre-immune mice as well as control Wistar rats and mice showed negative response proven by white 
gradation. The highest antibody titer in treated mouse serum was shown in 63 d incubation. The 
pregnancy on treated mice, control mice and Wistar rat occurred 100% until day 126; while the failure 
percentage on the treated mice was 4.5%. The pregnancy on treated mice occurred in 86 d incubation 
(1 rat), 100 d incubation (1 rat), and 126 d incubation (3 rats). Effective passive immunization on 
similar hospes occurred until day 63; while different hospes was ineffective. Antibodi anti-bZP3 was 
potential as a contraception through passive immunization on similar hospes. 
Key words: passive immunization, anti bZP3 (bovine Zona Pellucida)
ABSTRACT
Tujuan penelitian adalah membandingkan pengaruh imunisasi pasif anti bZP3 terhadap 
titer anti-anti bZP3 dan tingkat kebuntingan antara tikus putih dan mencit. Metode penelitian 
menggunakan rancangan acak lengkap pola faktorial. Faktor pertama jenis imunogen, imunisasi 
pada tikus perlakuan dengan imunogen 100 Pl anti bZP3 dalam 100 Pl Complete Freund’s Adjuvant 
(CFA), sedang mencit perlakuan diinjeksi 50 Pl anti bZP3 dalam 50 Pl CFA. Tikus dan mencit kontrol 
diimunisasi CFA dan Incomplete Freund’s Adjuvant (IFA) tanpa anti bZP3. Faktor kedua jenis hewan, 
yaitu tikus dan mencit, dan faktor ketiga lama inkubasi serum meliputi hari ke-38, 49, 63, 86, 100, dan 
126. Hasil dot blot pada tikus dan mencit perlakuan menunjukkan respon positif dengan noda warna 
biru, sedang tikus dan mencit pre-imun maupun tikus dan mencit kontrol respon negatif dengan 
noda warna putih. Titer antibodi tertinggi pada serum mencit perlakuan dengan lama inkubasi 
63 hari. Mencit perlakuan, mencit dan tikus kontrol terjadi kebuntingan 100% sampai hari ke-126, 
sedangkan  tikus perlakuan mengalami kegagalan 4,5%, kebuntingan terjadi pada inkubasi 86 hari (1 
ekor), 100 hari (1 ekor), dan 126 hari (3 ekor). Imunisasi pasif efektif pada hospes yang sama sampai 
pada hari ke 63, sebaliknya hospes berbeda tidak efektif. Antibodi anti-bZP3 mampu menekan 
efektivitas fertilisasi, sehingga berpeluang sebagai bahan kontrasepsi melalui imunisasi pasif atau 
imunokontrasepsi pada hospes yang sama.   
Kata kunci: imunisasi pasif, anti bZP3 (bovine Zona Pellucida)
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INTRODUCTION
Pregnancy could be prevented by using contracep-
tion methods that can be applied for both men and 
women. Some contraception methods are apparently 
considered less effective and safe as they are exposed 
to a number of side effects.  Recent studies found that 
zona pellucida (ZP) has shown to possess a strong im-
munogenicity. Therefore, a number of experiments have 
been conducted to develop a contraceptive vaccine using 
zona pellucida antigens (Koyama et al., 2005). Besides, 
it is also possible to utilize ovary waste from animal 
slaughtering houses. 
Prasad et al. (2000) states that fertilization could be 
prevented by using ZP glycoprotein. Basically, glyco-
protein recognizes sperm. The immunization with ZP 
glycoprotein molecule induces the growth of antibody 
for ZP that would inhibit the interaction between ZP 
and spermatozoa. Resulting in infertility, ZP could be 
used as contraception.
ZP3 is potential for immune-contraception target. 
Sumitro & Aulanni’am (2001) conducted a study on this 
field by injecting female Wistar rats with bZP3 (bovine 
Zona Pellucida) which later produce anti-bZP3.  Bovine 
Zona Pellucida, a specific antigen isolated from cow 
oocytes, is proven to be reversible and effective to stimu-
late the production of anti-bZP3. Immunologic reaction 
between anti-bZP3 and ZP inhibits the interaction be-
tween ovum and spermatozoa, and thus no fertilization 
occurs.
The high antigen characteristics of bZP3 molecule 
immunized actively, and the nature of ZP’s crossed re-
action requires further studies about the usage of ZP as 
immune-contraception. Therefore, further research about 
passive immunization to female Wistar rats and mice 
by using anti bZP3 produced by Wistar rat is needed. 
Female Wistar rats and mice are often used in research 
as they have high fertilities that support efficacy of 
reproduction. Nearly 90% scientific research use Wistar 
rats and mice as experimental animals because they 
grow up faster, do not show any seasonal marriage, and 
are easy to breed. In addition, they belong to the same 
family, Muridae (Moore, 2000). This study was aimed 
at comparing the effectiveness of passive immunization 
with anti bZP3 in Wistar rats and mice on antibody titer 
and pregnancy level.
Immunogen type Species type
Harvest time (d)
After I immuni-
zation (day to 1)
After I booster 
(day to 28)
After II booster 
(day to 56)
After III booster 
(day to 93)
Harvest to-
Control (adjuvant) Wistar rat 38 10 - - 1
49 21 - - 2
63 35 7 - 3
86 58 30 - 4
100 72 44 7 5
126 98 70 33 6
Mouse 38 10 - - 1
49 21 - - 2
63 35 7 - 3
86 58 30 - 4
100 72 44 7 5
126 98 70 33 6
Treated (Ab in 
adjuvant)
Wistar rat 38 10 - - 1
49 21 - - 2
63 35 7 - 3
86 58 30 - 4
100 72 44 7 5
126 98 70 33 6
Mouse 38 10 - - 1
49 21 - - 2
63 35 7 - 3
86 58 30 - 4
100 72 44 7 5
126 98 70 33 6
Table 1.The experimental design
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MATERIALS AND METHODS
This study employed factorial design experiment 
with completely randomized design. The first factor was 
immunogenic type [immunization only with adjuvant 
(control) and immunization with anti bZP3 in adjuvant 
(treatment)]. The second factor was animal type (female 
Wistar rat and female mice), and the third factor was the 
length of serum incubation (38, 49, 63, 86, 100, and 126 
d after anti-bZP3 immunization). The total of treatment 
was 2 x 2 x 6 = 24 treatment combinations; each of which 
was repeated three times, as shown in Table 1. 
Population in this study included female Wistar 
rats (Rattus norvegicus) and female mice (Mus musculus). 
Samples in this study included 36 female Wistar rats 
(R. norvegicus) aged 3 mo and weight of 250 g, and 36 
female mice (M. musculus) aged 2 mo, with the weight of 
30 g. The samples were taken from Pusvetma Surabaya. 
As the population was homogenous, the samples were 
taken randomly.
Immunization was done by subcutaneous injection 
in several locations of the body. The first immunization 
was conducted on the treatment Wistar rats with 100 
μl immunogen anti bZP3 in 100 μL Complete Freund’s 
Adjuvant (CFA); while the treatment mice were injected 
with 50 μL of anti bZP3 in 50 μL CFA. The repeated im-
munization was done on the following 10 d by increas-
ing 100 μL anti bZP3 in 100 μL Incomplete Freund’s 
Adjuvant (IFA) for the treatment Wistar rats; while the 
treatment mice were injected with 50 μL anti bZP3 in 50 
μL IFA. This repeated immunization is by definition a 
booster. Control Wistar rats and mice were only immu-
nized by CFA and IFA without anti bZP3. The schedule 
of booster II and III is shown in Table 1 and Table 2.
Serum harvesting was done by cutting the animals’ 
tail at about 50 mm from the tip of tail. The blood of the 
Wistar rats was taken 1000 μL, while the blood of mice 
was taken 500 μL. Serum harvesting was done six times, 
on day 38, 49, 63, 86, 100, and 126. The harvesting was 
done on day 38 for the reason that the animals had just 
been treated with booster I (10 d). The next harvesting 
was done on day 49 because on that day the testing 
animals were about to get booster II. The serum harvest-
ing was done on day 63 or seven days after booster II. It 
was expected that the titer level would be high. The next 
serum harvesting was done on day 86 for the reason that 
the animals had been treated with booster II for thirty 
days, and that it was a short period before booster III. 
Then, the serum harvesting was done on day 100 or 
seven days after booster III. Last, the serum harvest-
ing day was done on day 126 or thirty-three days after 
booster III (Figure 1).
Blood taken based on its incubation period was kept 
for 10 min at room temperature. The blood was then 
centrifuged at 1500 rpm for 15 min at room temperature. 
Precipitate was discarded; while supernatant as serum 
was transferred to eppendorf and kept at the tempera-
ture of -20 oC before purification. In purification process, 
serum was added with SAS 50% in the ratio of 1:1, 
homogenized by using vortex, and incubated for several 
minutes at 4 oC. After that, the serum was centrifuged at 
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Note: CFA= Complete Freund’s Adjuvant, IFA : Incomplete Freund’s Adjuvant
Time (d)
Treatment at animal
Explanation
Control Treatment
Day to 0 Blood taking - Pre immune
Day to 1 CFA injection Injection of anti bZP3 in CFA (1:1) -
Day to 28 IFA injection Injection of anti bZP3 in IFA (1:1) Booster of I
Day to 38 Blood taking Blood taking Mating; pregnancy test
Day to 49 Blood taking Blood taking Mating; pregnancy test
Day to 56 IFA injection Injection of anti bZP3 in IFA (1:1) Booster of II
Day to 63 Blood taking Blood taking Mating; pregnancy test
Day to 86 Blood taking Blood taking Mating; pregnancy test
Day to 93 IFA injection Injection of anti bZP3 in IFA (1:1) Booster of III
Dayto 100 Blood taking Blood taking Mating; pregnancy test
Day to 126 Blood taking Blood taking Mating; pregnancy test
Table 2. Immunization schedule and harvest time at Wistar rat and mouse
Figure 1. Scheme of research procedure
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Sample preparation of 
anti bZP3 from rats
Rat (100 µL anti bZP3; 
100 µL adjuvant)
Mouse (50 µL anti 
bZP3; 50 µL adjuvant)
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3000 rpm for 30 min at 4 oC. Supernatant was discarded. 
Precipitate was washed with SAS 50% (10 times as much 
as serum volume), homogenized by using vortex, and 
centrifuged at 3000 rpm for 30 min at 4 oC. Precipitate 
was added with 0.05 M phosphate buffer pH 7 at the 
same volume, and dialyzed in 0.01 M phosphate buffer 
pH 7 for 12 d at 4 oC. 
Antibody labeling was done by the conjunction 
of anti bZP3 as the results of anti bZP3 inductions to 
the animals based on their own incubation periods. 
Antigen specificity was done using Dot Blotting method. 
The change or degradation of colors was believed to 
be some indications to predict the existence of anti 
bZP3 in testing animal serum. The data were analyzed 
descriptively and qualitatively.
The result of antibody titer to the anti bZP3 was 
characterized based on the value of antibody titer using 
ELISQE technique and the method of indirect ELISA. 
The result was analyzed in descriptive to detect the dis-
tribution of each combination of the tested animals, and 
Anova to compare the effect of treatment combination to 
the free variables. If the result of Anova is found to be 
different, the test will be continued by using Duncan’s 
test (Sugiono, 2009).
Pregnancy test was conducted one night after mat-
ing, vagina plug was performed to ensure fertilization. 
When there was a plug, the surgery would be conducted 
on the following 10 d to see the existence of embryo. The 
pregnancy rate was obtained from dividing the number 
of pregnant treated animals by the number of mated 
animals in the treated group and was then multiplied by 
100%.
RESULTS AND DISCUSSION
The result of specification test to the IgG anti bZP3 
to antibody of IgG anti bZP3 in the Wistar rat and mouse 
serum induced by IgG anti bZP3 of Wistar rats showed 
a positive reaction with appearance of blue stain during 
incubation day 38, 49, 63, 86, 100, and 126 with 1/100 
and 1/200dilution. The blue stain degradation occurred 
in both dilutions; the 1/100 dilution had darker blue 
stain than 1/200 dilution. Wistar rat serum incubated in 
38 d appeared to have stronger blue stain compared to 
the other serum with different period of incubation. The 
lightest blue stain could be seen in the serum incubated 
for 126 d. In other case, generally the blue stain of mice 
was strong, but at 63 d incubation appeared to show the 
strongest blue (Figure 2). Blue stain was the complex 
of primary antibody antigen-antibody of secondary, 
labeled by alkaline phosphatase (AP) with western blue 
substrate in dot blotting result. Promega (2006) explained 
that secondary antibody-alkaline phosphatase conjugate 
recognized and was bound to the primary antibody. 
Color development substrate was added and was acted 
upon by the alkaline phosphatase (AP), resulting in a 
localized precipitate on the membrane. Besides, IgG anti 
bZP3 from the induced Wistar rats was recognized by 
the Wistar rats. It was not consideredasforeignsubstanc-
esand IgG anti bZP3 still functioned as the antibody. In 
dot blotting method, the blue stain appeared because 
the Wistar rats recognized bZP3; while the mice had im-
mune reaction because IgG anti bZP3 was assumed to be 
foreign substancesso it produced IgG anti IgG anti bZP3 
which also recognized antibody of IgG anti bZP3. This 
indicated that antigen was recognized by anti bZP3.
Control Wistar rats and mice induced only with 
adjuvant showed negative reaction in the incubation 
period of 38, 49, 63, 86, 100, and 126 d.  It was shown by 
one single color, white. It existed not onlyin 1/100 dilu-
tion, but also 1/200 dilution. Wistar rat and pre-immune 
mouse serum, which was not induced with adjuvant 
and IgG anti bZP3, also showed white color (Figure 
2). White color showed negative response because it 
did not form a complex of antigen - primary antibody 
- secondary antibody. This research used IgG antigen 
anti bZP3 of Wistar rat, antibody of IgG anti bZP3 as 
primary antibody, and anti rat IgG alkaline phosphatase 
(AP) conjugated as secondary antibody. White color also 
indicated that there was no binding complex between 
antigen-antibody primer-secondary antibody as there 
was not specific reaction between IgG anti bZP3 and 
antibody of control animal serum. As control animals 
were only injected with adjuvant, it had no and did 
not produce antibody that could recognize bZP3 and 
also antibody of IgG anti bZP3. As a result, there was 
no binding between primary antibodies and labeled 
secondary antibody. Moreover, the addition of substrate 
did not generate any reaction to the color. The serum of 
pre-immune Wistar rats and mice also resulted in white 
color; and the complex binding between antigen - pri-
mary antibody - secondary antibody did not appear.
Serum of mice appeared to be darker in blue than 
that of Wistar rat serum. It was because mice formed 
IgG anti IgG anti bZP3 and it had higher antibody titer 
than Wistar rat titer; while Wistar rats did not respond 
to form IgG anti IgG anti bZP3 because IgG anti bZP3 
was not assumed asforeignsubstances. IgG anti bZP3 
remained with its function as antibody. Therefore, the 
longer the period of incubation antibody titer, the less 
bZP3 appeared and the lighter the blue stain was. Wistar 
rats and mice with antibody 1/100 dilution had darker 
blue stain compared to dilution 1/200.
The antibody titer in the interaction of test animal 
type, type of injection, and the period of incubation were 
different. Based on the average value of antibody titer, 
it seemed that the highest antibody titer of adjuvant 
antibody of the injected mouse was in the incubation 
period of 63 d. Treated Wistar rats had smaller antibody 
serum titer than that of treated mice. This was because 
the IgG anti bZP3 of Wistar rats injected to the other 
Wistar rats remained with its function as antibody be-
cause IgG anti bZP3 of Wistar rats was not considered as 
foreignsubstances, so Wistar rats did not form IgG anti 
IgG anti bZP3. According to Baxter (2007), passive im-
munity refers to the process of providing IgG antibod-
ies to protect against infection; it gives immediate, but 
short-lived protection from several weeks to 3 or 4 mo 
at most. Passive immunity is usually classified as natu-
ral or acquired. Delves & Roitt (2005) also explain that 
passive administration of antibody has the advantage 
from its immediate effect, rather than having to wait for 
the immune response to build up before a contraceptive 
effect is obtained as in the case ofconventional immu-
PANTIWATI Media Peternakan
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nization. Furthermore, there is no requirement to break 
immunological tolerance, and individual variations in 
immune responses, therefore the level and duration 
of effectiveness are eliminated. However, passive im-
munization is likely to be more expensive and requires 
repeated administration. 
During incubation period of day 86, 100, and 126, 
the antibody titer was low and specification test also 
showed that the longer the incubation period, the more 
blue stain attenuated (Figure 3). The less antibody of 
bZP3 available would decrease the ability to block the 
reaction between ZP with spermatozoa. It caused the 
ZP3 to bind itself with specific protein of spermatozoa 
and stimulate initiative reaction of acrosome that result-
ed in fertilization led to pregnancy. Therefore, passive 
immunization with IgG anti bZP3 of Wistar rats in simi-
lar hospes, which was Wistar rat, was effective to inhibit 
fertilization until day 63. The degradation of antibody 
titer anti bZP3 could be followed by the degradation 
of antibody ability to block the ovum, so it enabled the 
binding of ZP with spermatozoa by involving receptor 
existing not only in oocytes, but also the spermatozoa.  
Based on its role, zona pellucida is an extracellular 
matrix that surrounds the oocyte and early embryo. It 
has primarily three or four glycol-proteins with various 
functions during fertilization and pre-implantation de-
velopment. The protein encoded by the gene is a struc-
ture component of the zona pellucida and functions in 
primary binding and sperm acrosome reactions. Gupta 
et al. (2011) also argued that zona pellucida glycol-pro-
teins, by virtue of their critical role in fertilization, have 
been proposed as candidate antigens for the develop-
ment of contraceptive vaccines. 
There were 36 mated mice, 18 control and 18 treated 
mice, and 36 mated Wistar rats, 18 control and 18 treated 
Wistar rats. Control Wistar rats, treated mice, and con-
trol mice showed 100% pregnancy from the period of in-
cubation of 38 until 126 d. The pregnancy rate on treated 
Wistar rats indicated different results in every period 
of incubation. The pregnancy rate of treated Wistar rats 
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Figure 3.  Titer antibody of Wistar rat and mouse for pre-im-
mune (-◊-): control Wistar rat (-□-); treated Wistar rat 
(-Δ-); control mouse (-x-); treated mouse (-o-).
Figure 4. Test result of pregnancy at wistar rat and for pre-im-
mune; control Wistar rat ( ); treated Wistar rat ( ); 
control mouse ( ); treated mouse ( ).
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Figure 2. Specification test for 63 d incubation period, yellow color for Wistar rats and red color for mice
Antigen 
concentrate
Anti rat- IgG-AP conjugate
1/1000
Serum deluting period of 63 d after immunization
1/100 1/100 1/200 1/200
1/200
1/200
Blank
Blank

  
 










































	








 	    








     !   $     "      ! 	
     &   ! %     

  #   ! '







	 
 	   





 
!





	 "   %   $ # 

  !    
	
T
it
er
 a
nt
ib
od
y 
(μ
g/
m
L)
168     December 2012
during the incubation period of 38, 49, and 63 d was 0%; 
during the incubation period of 86 and 100 d was 33%; 
and showed 100% pregnancy rate in day 126. The failure 
started to occur in day 126 (Figure 4). 
Treated Wistar rats induced with IgG anti bZP3 
were not pregnant during the incubation period of 38, 
49, and 63 d; but on day 86 they began to be pregnant 
followed by the treated Wistar rats with the length of 
incubation 100 and 126 d. This was because the IgG anti 
bZP3 of Wistar rats injected to other Wistar rat remained 
with its function as antibody; IgG anti bZP3 could block 
the reaction between ZP and spermatozoa; while ZP 
contained glicoprotein that recognized sperm, so the 
receptor became inactive at recognizing sperm. Process 
of reaction of acrosom did not occur and it disturbed the 
fertilization process. The disturbance would make fertil-
ization impossible. According to the finding of Barber & 
Fover (2000), antibody of IgG anti bZP3 in animal that 
experienced vaccination started to bind with the group 
of glycoprotein ZP3 (sperm receptor) of ZP in follicle 
de Graff. In this case, the first goal of antibody was the 
surface carbohydrate residue. Antibody of anti bZP3 
also blocked the fertilization by hindering the treads in 
charge of inducing the acrosome reaction and this in-
volved some parts of ZP protein. Antibody at the same 
species remained with its function and tied the ZP3 re-
ceptor up; therefore, it was predicted that it would cause 
the failure of fertilization. While antibody of different 
species caused immune reaction to solve the entering of 
foreign IgG, the clients would be able to do fertilization 
and pregnant (Gwatkin, 1982).
Mice induced with IgG anti bZP3 of Wistar rats 
became pregnant because in mice, there was a reaction 
of immunity to reject foreign IgG. Therefore, IgG anti 
bZP3 was a foreign object capable of showing immune 
response to specific antibody, such as IgG anti IgG anti 
bZP3. IgG anti IgG anti bZP3 formed by mice after being 
immunized with IgG anti bZP3 of Wistar rats was un-
able to hinder the binding process of sperm or could not 
block the reaction between ZP and spermatozoa, while 
ZP contained glycoprotein (sperm receptor) which rec-
ognized sperm. It made the receptor actively recognize 
sperm. The reactive process of acrosome occurred; there 
was nothing that troubled the process of fertilization. As 
a result, fertilization occurred. According to El-Mestrah 
et al. (2002), zone pellucida is a thick extracellular coat 
that surrounds growing oocytes, ovulated eggs, and 
pre-implantation embryos in mammal. The ZP contains 
receptor that mediates initial interaction between sperm 
and eggs a prelude to fertilization; it also mediates the 
relative species-specificity during gamete interaction, 
prevents polyspermy, and protects the developing 
embryo prior to implantation. Wassarman et al. (2004) 
explained that zone pellucida of mammals in general 
contained three types of constituent glycosidase protein 
(Zpl, ZP2, and Zp3) which play important roles in fertil-
ization as primary receptor reaction of spermatozoa rec-
ognition. Successful fertilization depends on the ability 
of sperm to penetrate extra cellular matrix surrounding 
eggs. In Wistar rats: ZP3 allows species-specific sperm 
binding, ZP2 mediates subsequent sperm binding, and 
ZP1 cross-links ZP2 and ZP3. Rankin et al. (2001) also 
explained that the ZP plays important roles in oocyte de-
velopment fertilization and early embryo development. 
The advantage of using active immunization is 
that it has reversible fertilities longer than passive 
immunization. Passive immunization relates to the 
existing substances; therefore, it works quickly, but it 
has no stimulation for the next production. It only has 
short-terminfluence. The other advantage of using active 
immunization is that it is effective for the immune-con-
traception in some different animals or species, so it has 
wide character of crossed reactions. However, it could 
possibly generate negative effects as genetically there are 
differences in species of antigen source from the induced 
hospes. There is a big chance for side effects. Passive 
immunization could only be effectively used for the 
same hospes within the same species. There is an equal 
genetic nature between species of antigen source and 
hospes, and thus negative effect could be prevented. In 
other words, passive immunization is more effective for 
immune-contraception. In ssence, contraceptive vaccines 
must be effective, long lasting, cheap and readily appli-
cable, and have no unacceptable side effects (Grandy & 
Rutberg, 2002).
CONCLUSION
Passive immunization with antibody bZP3 on 
female Wistar rats and mice showed different effects. 
Effective passive immunization on similar hospes oc-
curred until day 63; while different hospes was ineffec-
tive, proven by pregnancy. Antibodi bZP3 was proven to 
inhibit fertilization, and was potential as a contraception 
through passive immunization or immune-contracep-
tion on similar hospes. 
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